• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FDA Cracks Down on Improper Marketing of SARS-CoV-2 Antibody Tests

FDA Cracks Down on Improper Marketing of SARS-CoV-2 Antibody Tests

by Glenn S. Demby | Aug 4, 2020 | Articles, Clinical Diagnostics Insider, FDA-lca, G2 Insider-dtet, Lab Compliance Advisor

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
First Warning Letters Issued for Improper Marketing of SARS-CoV-2 Antibody Tests

First Warning Letters Issued for Improper Marketing of SARS-CoV-2 Antibody Tests

by Glenn S. Demby | Jul 14, 2020 | Articles, Enforcement-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
First Warning Letters Issued for Improper Marketing of SARS-CoV-2 Antibody Tests

Feds Launch First COVID-19 Testing Fraud Prosecution

by Glenn S. Demby | Jul 3, 2020 | Articles, DOJ-lca, Essential, False Claims-lca, Lab Compliance Advisor

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
First Warning Letters Issued for Improper Marketing of SARS-CoV-2 Antibody Tests

First Enforcement Action for Improper Marketing of SARS-CoV-2 Antibody Tests

by Glenn S. Demby | Jun 25, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Feds Charge Silicon Valley Med Tech Executive with Massive COVID-19 Stockholder Swindle

Feds Charge Silicon Valley Med Tech Executive with Massive COVID-19 Stockholder Swindle

by Glenn S. Demby | Jun 17, 2020 | Articles, Enforcement-nir, Essential, National Lab Reporter

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com